Table 1.
Demographic, cardiovascular, and neuropsychological characteristics of study participants.
| HIV-seropositive | HIV-seronegative | p | |
|---|---|---|---|
| Age when took Stroop N=920, 443 |
43.1±8.8 | 38.5±10.1 | <0.001 |
| Age when took SDMT N = 983, 464 |
41.7±8.8 | 37.2±10.0 | < 0.001 |
| CESD depression score N = 915, 438 |
13.7±12.4 | 12.8±11.9 | < 0.225 |
| WRAT number correct N = 776, 366 |
29.1±7.7 | 29.0±7.4 | 0.605 |
| Interference time N = 920, 467 |
132.7±37.7 | 124.9±3.1 | <0.001 |
| Symbol digit # correct N = 983, 467 |
41.5±12.6 | 44.4±11.8 | <0.001 |
| HDL Cholesterol N = 881, 418 |
49.9±16.9 | 54.6±13.5 | <0.001 |
| LDL cholesterol N = 805, 392 |
101.7±34.7 | 100.8±31.8 | 0.861 |
| CIMT N = 774, 371 |
0.73±0.12 | 0.72±0.12 | 0.020 |
| Estimated GFR N = 914, 439 |
95.3±27.4 | 99.5±23.3 | 0.005 |
| Ethnicity | 0.051 | ||
| White N = 120, 43 |
9.7% | 13.0% | |
| Hispanic N = 163/99 |
17.7% | 22.3% | |
| African-American N = 607, 281 |
66.0 % | 63.4% | |
| Other N = 30, 20 |
3.3% | 4.5% | |
| Diabetes mellitus present N = 152, 71 |
17.2% | 18.6% | 0.558 |
| Diabetes mellitus not present N = 730, 346 |
|||
| Any carotid lesion present N = 80, 26 |
10.3% | 7.0% | 0.081 |
| No carotid lesion present N = 694,395 |
|||
| History of MI N = 16, 13 |
1.7% | 2.9% | 0.165 |
| No History of MI N = 904,433 |
|||
| Hypertensive or on meds N = 282, 117 |
31.3% | 27.7% | 0.199 |
| Not hypertensive nor on meds N = 620,306 |
The number of participants with available data for each variable are listed in the cells in the left-most column. The first value is for HIV-seropositive, the second for HIV-seronegative. Except for percentages, values are means ± standard deviation.